Obstetric Surgical Site Infections
- 1 October 2015
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Obstetrics & Gynecology
- Vol. 126 (4), 708-715
- https://doi.org/10.1097/aog.0000000000001064
Abstract
To estimate whether morbidly obese gravid patients were less likely to develop a surgical site infection after receiving a higher dose of preoperative prophylactic antibiotics. A retrospective cohort study of morbidly obese pregnant women undergoing cesarean delivery was conducted at two tertiary care centers from 2008 to 2013. Exposure was defined as receiving 2 g compared with 3 g cefazolin preoperatively. Disease was defined by diagnosis of a surgical site infection using Centers for Disease Control and Prevention criteria. We estimated a sample size of 141 patients in each group for a 67% reduction (15% to 5%) in risk for a surgical site infection. There were 335 women included in the cohort with a median absolute weight of 310 (interquartile range 299-333) pounds. Forty-four (13.1%) women were diagnosed with a surgical site infection. There was no difference in surgical site infection among those women who received 2 g compared with 3 g cefazolin (13.1% [23/175] compared with 13.1% [21/160]; P=.996). Labor (crude odds ratio [OR] 2.31, 95% confidence interval [CI] 1.21-4.40), internal labor monitoring (OR 2.78, 1.45-5.31), blood loss greater than 1,500 mL (OR 2.15, 1.09-5.78), and staple closure (OR 2.2, 1.15-4.21) were associated with a surgical site infection among the entire cohort. After multivariable analysis, blood loss greater than 1,500 mL (adjusted OR 3.32, 1.32-8.37) and staple closure (adjusted OR 2.45, 1.19-5.02) remained associated with an increased risk for a surgical site infection, whereas 3 g cefazolin still was not associated with reduced risk for a surgical site infection (adjusted OR 1.33, 0.64-2.74). In our multicenter retrospective cohort study, preoperative 3 g cefazolin prophylaxis administered to morbidly obese gravid patients did not reduce surgical site infections. III.Keywords
This publication has 13 references indexed in Scilit:
- Cefazolin Prophylaxis in Obese Women Undergoing Cesarean DeliveryObstetrics & Gynecology, 2015
- Plasma and Tissue Cefazolin Concentrations in Obese Patients Undergoing Cesarean Delivery and Receiving Differing Pre-Operative Doses of DrugSurgical Infections, 2013
- Clinical practice guidelines for antimicrobial prophylaxis in surgeryAmerican Journal of Health-System Pharmacy, 2013
- Cefazolin Dosing for Surgical Prophylaxis in Morbidly Obese PatientsSurgical Infections, 2012
- Plasma and Tissue Pharmacokinetics of Cefazolin in Patients Undergoing Elective and Semielective Abdominal Aortic Aneurysm Open Repair SurgeryAntimicrobial Agents and Chemotherapy, 2011
- Practice Bulletin No. 120: Use of Prophylactic Antibiotics in Labor and DeliveryObstetrics & Gynecology, 2011
- Risk factors for wound infection following cesarean deliveriesInternational Journal of Gynecology & Obstetrics, 2005
- Risk factors for postcesarean surgical site infectionPublished by Ovid Technologies (Wolters Kluwer Health) ,2000
- The Impact of Surgical-Site Infections in the 1990s: Attributable Mortality, Excess Length of Hospitalization, And Extra CostsInfection Control & Hospital Epidemiology, 1999
- Guideline for Prevention of Surgical Site Infection, 1999Infection Control & Hospital Epidemiology, 1999